Enoxaparin and rivaroxaban have different effects on human mesenchymal stromal cells in the early stages of bone healing

[摘要] ObjectivesVenous thromboembolism (VTE) is a major potential complication following orthopaedic surgery. Subcutaneously administered enoxaparin has been used as the benchmark to reduce the incidence of VTE. However, concerns have been raised regarding the

[学科分类] 骨科学

[关键词] rivaroxaban;enoxaparin;human mesenchymal stromal cells (MSCs);low-molecular-weight heparins (LMWH);bone healing